Marshall Wace North America’s DexCom DXCM Stock Holding History

Marshall Wace North America’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,700	Closed	-$2.22M	–	1527
2021 Q1	$2.22M	Buy	+24,700	New	+$2.32M	0.01%	798
2020 Q3	–	Sell	-5,880	Closed	-$596K	–	1269
2020 Q2	$596K	Sell	5,880 -2,256	-28%	-$202K	﹤0.01%	891
2020 Q1	$548K	Buy	8,136 +1,660	+26%	+$103K	﹤0.01%	736
2019 Q4	$354K	Sell	6,476 -96,416	-94%	-$4.57M	﹤0.01%	876
2019 Q3	$3.84M	Buy	+102,892	New	+$4M	0.02%	416
2018 Q4	–	Sell	-126,768	Closed	-$4.53M	–	1512
2018 Q3	$4.53M	Buy	126,768 +49,724	+65%	+$1.54M	0.03%	338
2018 Q2	$1.83M	Sell	77,044 -181,788	-70%	-$3.85M	0.01%	791
2018 Q1	$4.8M	Buy	+258,832	New	+$3.83M	0.02%	581
2013 Q4	–	Sell	-518,928	Closed	-$3.66M	–	726
2013 Q3	$3.66M	Buy	+518,928	New	+$3.29M	0.11%	198

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Marshall Wace North America's DXCM Position: Q2 2021 in Review

Marshall Wace North America sold out of DexCom (DXCM) in Q2 2021, closing a stake of 24,700 shares — an estimated $2.22M sold.

Marshall Wace North America first reported a position in DXCM in Q3 2013 and held it in 9 quarters. The position peaked at $4.8M in Q1 2018. 728 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

Marshall Wace North America reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 24,700 DexCom shares in Q2 2021, an estimated $2.22M.
Marshall Wace North America first reported a position in DexCom in Q3 2013 and held it in 9 quarters.
Marshall Wace North America's DexCom position peaked at $4.8M in Q1 2018.
728 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.